Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants

  • Authors:
    • Yingchun Li
    • Huihan Wang
    • Rong Zhang
    • Guojun Zhang
    • Ying Yang
    • Zhuogang Liu
  • View Affiliations / Copyright

    Affiliations: Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, Liaoning 110021, P.R. China
  • Pages: 1934-1938
    |
    Published online on: November 30, 2018
       https://doi.org/10.3892/ol.2018.9783
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the effect of benzoxime on leukemia RBL‑1 cell proliferation and a leukemic Sprague‑Dawley rat model. Proliferation of RBL‑1 cells was determined using an MTT assay. Sprague‑Dawley rats were assigned randomly into three groups of 10 animals each, where the positive control group was administered an intravenous injection of normal saline, the negative control group was administered 1x106 RBL‑1 cells and the treatment group was administered with 1x106 RBL‑1 cells and then benzoxime (50 mg/kg/day) for 1 week. Increased dosage of benzoxime reduced RBL‑1 cell viability from 92 at 2 µM to 21% at 12 µM after 24 h. Benzoxime treatment prevented the loss of body weight in the rats with leukemia. Compared with the negative control rats, the body weight was determined to be significantly reduced (P<0.05) in the positive control rats. The weight of the spleen and liver was determined to be significantly increased (P<0.02) in the positive control rats and the benzoxime‑treated rats compared with that in the negative control group on day 35 of RBL‑1 cell implantation. Analysis of leukocytes in rats on day 35 demonstrated a significant reduction (P<0.05) in the cluster of differentiation (CD)11b and CD45 level in the positive control group compared with that in the negative control group. The level of CD11b and CD45 was determined to be similar in the rats in the benzoxime treatment and negative control groups. Analysis of the level of serum glutamic pyruvic transaminase, serum glutamic oxaloacetic transaminase and blood urea nitrogen indicated that all three components exhibited no significant changes in the rats following treatment with benzoxime compared with the component levels in the negative control group. The levels of these three components were in the normal range in rats treated with benzoxime on day 35 of cell implantation. These data demonstrated that the liver and kidneys are not influenced by benzoxime in rats with leukemia. In summary, the present study demonstrated that benzoxime efficiently prevents leukemia growth without inducing any harmful effects in rat models through targeting CD11b and CD45 level; thus, benzoxime should be evaluated further regarding its use in the treatment of leukemia.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Liu YQ, Zhao FJ, Chen WQ, et al: An analysis of incidence and mortality of leukemia in China, 2009. China Cancer. 7:528–534. 2013.

2 

ESPíRITO Santo AE, Chacim S, Ferreira I, Leite L, Moreira C, Pereira D, Dantas Brito MD, Nunes M, Domingues N, Oliveira I, et al: Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia. Oncol Lett. 12:262–268. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Li WX, Li YK and Lin HT: Correlation between survivin polymorphism and acute leukemia of children. Expt Ther Med. 15:2941–2945. 2018.

4 

Jiang KL, Ma PP, Yang XQ, Zhong L, Wang H, Zhu XY and Liu BZ: Neutrophil elastase and its therapeutic effect on leukemia cells. Mol Med Rep. 12:4165–4172. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Yildirim R, Gundogdu M, Ozbıcer A, Kiki I, Erdem F and Dogan H: Acute promyelocytic leukemia, centre, experience, Turkey. Transfus Apher Sci. 48:45–49. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Guo J, Chang CK and Li X: Recent advances of molecular mechanisms influencing prognosis of myelodysplastic syndrome-review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 20:1020–1024. 2012.(In Chinese). PubMed/NCBI

7 

Kinoshita K and Funauchi M: Therapeutic effect of retinoic acid in lupus nephritis. Nihon Rinsho Meneki Gakkai Kaishi. 35:1–7. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI

8 

Flatt T, Neville K, Lewing K and Dalal J: Successful treatment of fanconi anemia and T-cell acute lymphoblastic leukemia. Case Report Hematol. 2012:3963952012.

9 

Estey EH: Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 87:89–99. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Wang TT and Chen BA: Leukemia stem/progenitor cells and target therapy for leukemia-review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 18:1654–1658. 2010.(In Chinese). PubMed/NCBI

11 

Zhai YK, Pan YL, Niu YB, Li CR, Wu XL, Fan WT, Lu TL, Mei QB and Xian CJ: The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro. Int J Endocrinol. 2014:9219542014. View Article : Google Scholar : PubMed/NCBI

12 

Yogesh HS, Chandrashekhar VM, Katti HR, Ganapaty S, Raghavendra HL, Gowda GK and Goplakhrishna B: Anti-osteoporotic activity of aqueous-methanol extract of Berberis aristata in ovariectomized rats. J Ethnopharmacol. 134:334–338. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Lee WS, Lee EG, Sung MS and Yoo WH: Kaempferol inhibits IL-1β-stimulated, RANKL-mediated osteoclastogenesis via downregulation of MAPKs, c-Fos, and NFATc1. Inflammation. 37:1221–1230. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Tyagi AM, Srivastava K, Singh AK, Kumar A, Changkija B, Pandey R, Lahiri S, Nagar GK, Yadav DK, Maurya R, et al: Formononetin reverses established osteopenia in adult ovariectomized rats. Menopause. 19:856–863. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, Kocak A and Yologlu S: Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem. 294:137–144. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Gatson JW, Liu MM, Abdelfattah K, Wigginton JG, Smith S, Wolf S and Minei JP: Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury. J Trauma Acute Care Surg. 74:470–475. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Lin CJ, Chen TH, Yang LY and Shih CM: Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis. 5:e11472014. View Article : Google Scholar : PubMed/NCBI

18 

Lin C, Yang JS, Tsai SC, Lin CF and Lee MR: In vivo evaluation of the synthesized novel 2-benzyloxybenzaldehyde analog CCY-1a-E2 for the treatment of leukemia in the BALB/c mouse WEHI-3 allograft model. Oncol Lett. 5:777–782. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ and Holz MK: Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle. 13:371–382. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Li H, Zhai Z, Liu G, Tang T, Lin Z, Zheng M, Qin A and Dai K: Sanguinarine inhibits osteoclast formation and bone resorption via suppressing RANKL-induced activation of NF-κB and ERK signaling pathways. Biochem Biophys Res Commun. 430:951–956. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Mackraj I, Govender T and Gathiram P: Sanguinarine. Cardiovasc Ther. 26:75–83. 2008.PubMed/NCBI

22 

Chung JG, Yang JS, Huang LJ, Lee FY, Teng CM, Tsai SC, Lin KL, Wang SF and Kuo SC: Proteomic approach to studying the cytotoxicity of YC-1 on U937 leukemia cells and antileukemia activity in orthotopic model of leukemia mice. Proteomics. 7:3305–3317. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Lu CC, Yang JS, Chiang JH, Hour MJ, Lin KL, Lin JJ, Huang WW, Tsuzuki M, Lee TH and Chung JG: Novel quinazolinone MJ-29 triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic mice. PLoS One. 7:e368312012. View Article : Google Scholar : PubMed/NCBI

24 

Chiang JH, Yang JS, Ma CY, Yang MD, Huang HY, Hsia TC, Kuo HM, Wu PP, Lee TH and Chung JG: Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways. Chem Res Toxicol. 24:20–29. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Hsu SC, Ou CC, Li JW, Chuang TC, Kuo HP, Liu JY, Chen CS, Lin SC, Su CH and Kao MC: Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G(2)/M cell cycle arrest. J Ethnopharmacol. 120:394–401. 2008. View Article : Google Scholar : PubMed/NCBI

26 

Yang JS, Wu CC, Kuo CL, Lan YH, Yeh CC, Yu CC, Lien JC, Hsu YM, Kuo WW, Wood WG, et al: Solanum lyratum extracts induce extrinsic and intrinsic pathways of apoptosis in WEHI-3 murine leukemia cells and inhibit allograft tumor. Evid Based Complement Alternat Med. 2012:2549602012. View Article : Google Scholar : PubMed/NCBI

27 

Li J and Sartorelli AC: Synergistic induction of the differentiation of WEHI-3B D+ myelomonocytic leukemia cells by retinoic acid and granulocyte colony-stimulating factor. Leuk Res. 16:571–576. 1992. View Article : Google Scholar : PubMed/NCBI

28 

Barr RD and Harnish D: Induction of differentiation of HL-60 and WEHI-3B D+ leukemia cells by lithium chloride. Leuk Res. 17:1017–1018. 1993. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Y, Wang H, Zhang R, Zhang G, Yang Y and Liu Z: Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants. Oncol Lett 17: 1934-1938, 2019.
APA
Li, Y., Wang, H., Zhang, R., Zhang, G., Yang, Y., & Liu, Z. (2019). Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants. Oncology Letters, 17, 1934-1938. https://doi.org/10.3892/ol.2018.9783
MLA
Li, Y., Wang, H., Zhang, R., Zhang, G., Yang, Y., Liu, Z."Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants". Oncology Letters 17.2 (2019): 1934-1938.
Chicago
Li, Y., Wang, H., Zhang, R., Zhang, G., Yang, Y., Liu, Z."Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants". Oncology Letters 17, no. 2 (2019): 1934-1938. https://doi.org/10.3892/ol.2018.9783
Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Wang H, Zhang R, Zhang G, Yang Y and Liu Z: Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants. Oncol Lett 17: 1934-1938, 2019.
APA
Li, Y., Wang, H., Zhang, R., Zhang, G., Yang, Y., & Liu, Z. (2019). Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants. Oncology Letters, 17, 1934-1938. https://doi.org/10.3892/ol.2018.9783
MLA
Li, Y., Wang, H., Zhang, R., Zhang, G., Yang, Y., Liu, Z."Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants". Oncology Letters 17.2 (2019): 1934-1938.
Chicago
Li, Y., Wang, H., Zhang, R., Zhang, G., Yang, Y., Liu, Z."Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL‑1 xenotransplants". Oncology Letters 17, no. 2 (2019): 1934-1938. https://doi.org/10.3892/ol.2018.9783
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team